The whole model showed 55.1% of total variability and the analysis extracted 4 factors which we have entitled: Dyslipidemia-redox balance factor (TOS, TAS, PON1, PAB and PCSK9), Lipid risk-inflammation protein related factor (TG, CRP, SHG and ApoB100), Metabolic-related lipid protective factor (ALT, AST and ApoA1) and Intervention-related metabolic antioxidant factor (SOD, glucose and octacosanol supplement status – yes/no). The gene discussed is PCSK9; the disease is metabolic syndrome.